» Articles » PMID: 24312268

Relationships Among Smoking Habits, Airflow Limitations, and Metabolic Abnormalities in School Workers

Overview
Journal PLoS One
Date 2013 Dec 7
PMID 24312268
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease is caused mainly by habitual smoking and is common among elderly individuals. It involves not only airflow limitation but also metabolic disorders, leading to increased cardiovascular morbidity and mortality.

Objective: We evaluated relationships among smoking habits, airflow limitation, and metabolic abnormalities.

Methods: Between 2001 and 2008, 15,324 school workers (9700 males, 5624 females; age: ≥ 30 years) underwent medical checkups, including blood tests and spirometry. They also responded to a questionnaire on smoking habits and medical history.

Results: Airflow limitation was more prevalent in current smokers than in ex-smokers and never-smokers in men and women. The frequency of hypertriglyceridemia was higher in current smokers in all age groups, and those of low high-density-lipoprotein cholesterolemia and diabetes mellitus were higher in current smokers in age groups ≥ 40 s in men, but not in women. There were significant differences in the frequencies of metabolic abnormalities between subjects with airflow limitations and those without in women, but not in men. Smoking index was an independent factor associated with increased frequencies of hypertriglyceridemia (OR 1.015; 95% CI: 1.012-1.018; p<0.0001) and low high-density-lipoprotein cholesterolemia (1.013; 1.010-1.016; p<0.0001) in men. Length of smoking cessation was an independent factor associated with a decreased frequency of hypertriglyceridemia (0.984; 0.975-0.994; p = 0.007).

Conclusions: Habitual smoking causes high incidences of airflow limitation and metabolic abnormalities. Women, but not men, with airflow limitation had higher frequencies of metabolic abnormalities.

Citing Articles

Pathways from insulin resistance to incident cardiovascular disease: a Bayesian network analysis.

Tian X, Chen S, Xia X, Xu Q, Zhang Y, Zheng C Cardiovasc Diabetol. 2024; 23(1):421.

PMID: 39574129 PMC: 11583553. DOI: 10.1186/s12933-024-02510-w.


Much Lower Prevalence and Mortality of Chronic Obstructive Pulmonary Disease in Japan Than in the United States Despite Higher Smoking Rates: A Meta-Analysis/Systematic Review.

Sekikawa A, Li M, Joshi N, Herbert B, Tilves C, Cui C J Epidemiol. 2024; 35(2):90-99.

PMID: 39034109 PMC: 11706673. DOI: 10.2188/jea.JE20240085.


The Effects of Smoking on Metabolic Syndrome and Its Components Using Causal Methods in the Iranian Population.

Khodamoradi F, Nazemipour M, Mansournia N, Yazdani K, Khalili D, Mansournia M Int J Prev Med. 2021; 12:118.

PMID: 34760129 PMC: 8551769. DOI: 10.4103/ijpvm.ijpvm_45_21.


The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: A systematic review.

Lee P, Forey B, Thornton A, Coombs K F1000Res. 2019; 7:204.

PMID: 30800285 PMC: 6367657. DOI: 10.12688/f1000research.14002.1.


Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis.

Maneiro J, Souto A, Gomez-Reino J Clin Rheumatol. 2017; 36(5):1167-1172.

PMID: 28108800 DOI: 10.1007/s10067-017-3537-5.

References
1.
Kuzuya M, Ando F, Iguchi A, Shimokata H . Effect of smoking habit on age-related changes in serum lipids: a cross-sectional and longitudinal analysis in a large Japanese cohort. Atherosclerosis. 2005; 185(1):183-90. DOI: 10.1016/j.atherosclerosis.2005.05.040. View

2.
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S . Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2006; 115(4):450-8. DOI: 10.1161/CIRCULATIONAHA.106.637793. View

3.
Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

4.
Sidney S, Sorel M, Quesenberry Jr C, DeLuise C, Lanes S, Eisner M . COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128(4):2068-75. DOI: 10.1378/chest.128.4.2068. View

5.
Benowitz N . Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988; 319(20):1318-30. DOI: 10.1056/NEJM198811173192005. View